Abstract
The nucleoside analog 5-azacytidine (5-aza-C) was first synthesized in Czechoslovakia in 1963 (Piskala and Sorm, 1964); it also has been isolated from streptoverticillium (Streptoverticillus ladakanus, Hanka et al. 1966; Bergy and Herr, 1966). 5-Aza-C differs from cytidine only by the inclusion of a nitrogen atom in the 5 position of the pyrimidine ring (Figure 9.1). It was originally developed for use as a cancer chemotherapeutic agent and is still-used in the treatment of certain types of acute myelogenous leukemia. However, recent interest in the drug has been directed toward its remarkable ability to induce the expression of repressed genes in eukaryotic cells and to act as an inhibitor of DNA methylation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adams RLP, Fulton J, Kirk D: The effect of 5-azadeoxycytidine on cell growth and DNA methylation. Biochim Biophys Acta 1982; 697: 286–294.
Altanerova V: Virus production induced by various chemical carcinogens in a virogenic hamster cell line transformed by Rous sarcoma virus. J Natl Cancer Inst 1972; 49: 1375–1380.
Anderson EP: Nucleoside and nucleotide kinases; in Boyer PD (ed): The Enzymes. New York, Academic Press, 1973, vol 9 pp 49–96.
Banerjee A, Benedict WF: Production of sister chromatid exchanges by various cancer chemotherapeutic agents. Cancer Res 1979; 39: 797–799.
Beisler JA: Isolation, characterization and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine. J Med Chem 1978; 21: 204–208.
Beisler JA, Abbasi MM, Driscoll JS: Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine. Cancer Treatment Rep 1976; 60: 1671–1674.
Benedict WF, Banerjee A, Gardner A, Jones PA: Induction of morphological transformation in mouse C3H 101/2 clone 8 cells and chromosomal damage in hamster A(T1)Cl-3 cells by cancer chemotherapeutic agents. Cancer Res 1977; 37: 2202–2208.
Ben-Sasson SA, Klein G: Activation of the Epstein-Barr virus genome by 5-azacytidine in latently infected human lymphoid lines. Int J Cancer 1981; 28: 131–135.
Bergy ME, Herr RR: Microbial production of 5-azacytidine. II. Isolation and chemical structure. Antimicrob Ag Chemother 1966, pp 625–630.
Bodner AJ, Ting RC, Gallo RC: Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate. J Natl Cancer Inst 1981; 67: 1025–1030.
Bolander FF: The effect of 5-azacytidine on mammary gland differentiation in vitro. Biochem Biophys Res Commun 1983; 111: 150–155.
Bouchard J, Momparler RL: Incorporation of 5-Aza-21-deoxycytidine-51-triphosphate into DNA: interactions with mammalian DNA polymerase and DNA methylase. Mol Pharmacol 1983; 24: 109–114.
Boyd AW, Schrader JW: Derivation of macrophage-like lines from the pre-B lymphoma ABLS 8.1 using 5-azacytidine. Nature 1982; 297: 691–694.
Caputto R: Nucleotide kinases, in Boyer PD, Lardy H, Myrback K (eds): The Enzymes. New York, Academic Press, 1962, vol 6 pp 133–138.
Chabot GG, Bouchard J, Momparler RL: Kinetics of deamination of 5-aza21deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside. Biochem. Pharmacol 1983; 32: 1327–1328.
Chambers JC, Taylor JH: Induction of sister chromatid exchanges by 5-fluorodeox- ycytidine: correlation with DNA methylation. Chromosome 1982; 85: 603–609.
Chan KK, Giannini DD, Staroscik JA, Sadee W: 5-Azacytidine hydrolysis kinetics measured by high pressure liquid chromatography and “C-NMR spectroscopy. J Pharm Sci 1979; 68: 807–812.
Charache S, Dover GJ, Smith KD, et al: Treatment of sickle cell anemia with 5azacytidine. Blood 1982; 60 (suppl 1): 449.
Chou T-C, Burchenal JH, Fox JJ, Watanabe KA, Chu CK, Philips FS: Metabolism and effects of 5-(ß-D-ribofuranosyl) isocytosine in P815 cells. Cancer Res 1979; 39: 720–728.
Christman JK, Mendelsohn N, Herzog D, Schniederman N: Effect of 5-azacytidine on differentiation and DNA methylation in human promyelocytic leukemia cells (HL-60). Cancer Res 1983; 43: 763–769.
Clough DW, Kunkel LM, Davidson RL: 5-Azacytidine induced reactivation of a Herpes Simplex thymidine kinase gene. Science 1982; 216: 70–73.
Compere SJ, Palmiter RD: DNA methylation controls the inducibility of the mouse metallothionein-1 gene in lymphoid cells. Cell 1981; 25: 233–240.
Constantinides PG: Myogenic Conversion of Cultured Cells by Azapyrimidines. M.Sc. Thesis, University of Stellenbosch Medical School, South Africa, 1977.
Constantinides PG, Jones PA, Gevers W: Functional striated muscle cells from nonmyoblast precursors following 5-azacytidine treatment. Nature 1977; 267: 364–366.
Constantinides PG, Taylor SM, Jones PA: Phenotypic conversion of cultured mouse embryo cells by aza pyrimidine nucleosides. Devel Biol 1979; 66: 57–71.
Creusot F, Acs G, Christman JK: Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-21-deoxycytidine. J Biol Chem 1982; 257: 2041–2948.
DeSimone J, Heller P, Hall L, Zwiers D: 5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc Natl Acad Sci (USA) 1982; 79: 4428–4431.
Flatau E, Jones PA: Production of 5-azacytidine resistant cell lines (submitted). Friedman S: The effect of azacytidine on E. Coli DNA methylase. Biochem Biophys Res Commun 1979; 89: 1324–1333.
Friedman S: The inhibition of DNA (Cytosine-5) Methylases by 5-Azacytidine—The effect of azacytosine-containing DNA. Mol Pharmacol 1981; 19: 314–320.
Frost P, Kerbel RS: The selection of strongly immunogenic “Tum-” variants from tumors at high frequency using 5-azacytidine. J Exptl Med (1984); (in press).
Fucik V, Zandrael S, Sormova Z, Sorm F: Mutagenic effect of 5-azacytidine in bacteria. Coll Czech Chem Comm 1965; 30: 2883–2886.
Gasson JC, Ryden T, Bourgeois S: Role of de novo DNA methylation in the glucocorticoid resistance of a T-lymphoid cell line. Nature 1983; 302: 621–632.
Graves JAM: 5-Azacytidine-induced re-expression of alleles on the inactive X-chromosome in a Mus musculus X M. caroli cell line. Exp Cell Res 1982;141:99–105.
Groudine M, Eisenman R, Weintraub H: Chromatin structure of endogenous retro-viral genes and activation by an inhibitor of DNA methylation. Nature 1981; 292: 311–317.
Halle S: 5-Azacytidine as a mutagen for arboviruses. J Virol 1968;2:1228–1229.
Hanka LJ, Evans JS, Mason DJ, Dietz A: Microbial production of 5-azacytidine. Production and biological activity. Antimicrob Ag Chemother 1966, pp 619–624.
Harris M: Induction of thymidine kinase in enzyme-deficient Chinese hamster cells. Cell 1982; 29: 483–492.
Hoffmann JW, Steffen D, Gusella J, Tabin C, Bird S, Cowing D, Weinberg RA: DNA methylation affecting the expression of murine leukemia proviruses. J Virol 1982; 44: 144–157.
Israili ZH, Volger WR, Mingioli ES, Pirkle JL, Smithwick RW, Goldstein JH: The disposition and pharmacokinetics in humans of 5-azacytidine administered intravenously as a bolus or by continuous infusion. Cancer Res 1976; 36: 1453–1461.
Ivarie RD, Morris JA: Induction of prolactin deficient variants of CH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine a DNA methylation inhibitor. Proc Natl Acad Sci (USA) 1982; 79: 2967–2970.
Jones PA, Taylor SM: Hemimethylated duplex DNAs prepared from 5-azacytidine treated cells. Nucl Acids Res 1981; 9: 2933–2947.
Jones PA, Taylor SM: Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85–93.
Jones PA, Taylor SM, Mohandas T, Shapiro L I: Cell cycle specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc Natl Acad Sci (USA) 1982; 79: 1215–1219.
Karon M, Benedict WF: Chromatid breakage: Differential effect of inhibitors of DNA synthesis during G2 phase. Science 1972; 178: 62–63.
Landotph JR, Jones PA: Mutagenicity of 5-azacytidine and related nucleosides in C3H/10T1/2 C18 and V79 cells. Cancer Res 1982; 42: 817–823.
Lee TT, Karon M: Inhibition of protein synthesis in 5-azacytidine-treated HeLa cells. Biochem Pharmacol 1976; 25: 1737–1742.
Lee T, Karon M, Momparler RL: Kinetic studies on phosphorylation of 5-azacytidine with the purified uridine-cytidine kinase from calf thymus. Cancer Res 1974; 34: 2482–2488.
Lester SC, Korn NJ, DeMars R: Derepression of genes on the human inactive X-chromosome: evidence for differences in locus-specific rates of derepression and rates of transfer of active and inactive genes after DNA-mediated transformation. Somatic Cell Genet, 1982; 8: 265–284.
Ley TJ, DeSimone J, Anagnou NP, Heller GH, Humphries RK, Turner PH, Young NS, Heller P, Nienhius AW: 5-Azacytidine selectively increases ß-globin synthesis in a patient with ß + thalassemia. N Engl J Med 1982; 307: 1469–1475.
Ley T, et al: Personal communication, 1983.
Liacouras AS, Anderson EP: Uridine-cytidine kinase IV. Kinetics of the competition between 5-azacytidine and the 2 natural substrates. Mol Pharmacol 1979; 15: 331–340.
Li LH, Olin EJ, Buskirk HH, Rineke LM: Cytotoxicity and mode of action of 5azacytidine on L1210 leukemia. Cancer Res 1970; 2760–2769.
Lin K-T, Momparler RL, Rivard GE: High performance liquid chromatographic analysis of chemical stability of 5-aza-21-deoxycytidine. J Pharm Sci 1981; 70: 1228–1232.
Lu L-JW, Chiang GH, Medina D, Randerath K: Drug effects on nucleic acid modification. 1. Specific effect of 5-azacytidine on mammalian transfer RNA modification in vivo. Biochem Biophys Res Commun 1976; 68: 1094–1101.
Lu L-JW, Randerath K: Effects of 5-azacytidine on transfer RNA methyltransferases. Cancer Res 1979; 39: 940–948.
Lu L-JW, Randerath K: Mechanism of 5-azacytidine induced transfer RNA cytosine5-methyltransferase deficiency. Cancer Res 1980; 40: 2701–2705.
Lu L-J, Tseng WC, Randerath K: Effects of 5-fluorocytidine on mammalian transfer RNA and transfer RNA methyltransferases. Biochem Pharmacol 1979; 28: 489–495.
Macleod CL, Hyman R, Bourgeois S, Hays E: Differentiation of a T Lymphoma Line in vitro. UCLA Symposium, 1983.
Marquardt H, Marquardt M: Induction of malignant transformation and mutagenesis in cell cultures by cancer chemotherapeutic agents. Cancer (Phil) 1977; 40: 1930–1934.
McGeady ML, Jhappan C, Ascocione R, Van de Woude GF: In vitro methylation of specific regions of the cloned moloney sarcoma virus genone inhibits its transforming activity. Cell Mol Biol 1982; 3: 305–314.
Mohandas T, Sparkes RS, Shapiro LJ: Reactivation of an inactive human X chromosome: Evidence for X inactivation by DNA methylation. Science 1981; 211: 393–396.
Momparler RL, Derse D: Kinetics of phosphorylation of 5-aza-21-deoxycytidine by deoxycytidine kinase. Biochem Pharmacol 1979; 28: 1443–1444.
Momparler RL, Goodman J: In vitro cytotoxic and biochemical effects of 5-aza-21deoxycytidine. Cancer Res 1977; 37: 1636–1639.
Momparler RL, Siegel S, Avila F, Lee T, Karon, M: Effect of tRNA from 5-azacytidine treated hamster fibrosarcoma cells on protein synthesis in vitro in a cell free system. Biochem Pharmacol 1976; 25: 389–392.
Mondal S, Heidelberger C: Inhibition of induced differentiation of C3H/10T1/2 Clone 8 mouse embryo cells by tumor promoters. Cancer Res 1980; 40: 334–338.
National Cancer Institute: Bioassay of 5-azacytidine for possible carcinogenicity (Technical report series No. 42, DHEW Publ. No. [NIH] 78–842 ). Washington, DC, United States Government Printing Office, 1978.
Nesnow S, Heidelberger C: The effects of modifiers of microsomal enzymes on chemical oncogenesis in cultures of C3H mouse cell lines. Cancer Res 1976; 36: 1801 1808.
Niwa O, Sugahara T: 5-Azacytidine induction of mouse endogenous type C virus and suppression of DNA methylation. Proc Natl Acad Sci (USA) 1981; 78: 6290–6294.
Notari RE, DeYoung JL: Kinetics and mechanism of degradation of the antileukemic agent 5-azacytidine in aqueous solution. J Pharm Sci 1975; 64: 1148–1157.
Piskala A, Sorm F: Nucleic acids components and their analogues. Synthesis of 1glycosyl derivatives of 5-azauracil and 5-azacytosine. Coll Czech Chem Commun 1964; 29: 2060–2067.
Pithova P, Piskala A, Pitha J, Sorm F: Nucleic acids components and their analogues LXVI. Hydrolysis of 5-azacytidine and its connection with biological activity. Coll Czech Commun 1965; 30: 2801–2811.
Pringle CR: Genetic characteristics of conditional lethal mutants of vesicular stomatitus virus induced by 5-fluorouracil, 5-aza-cytidine and ethyl methane sulfonate. J Virol 1979; 5: 559–567.
Reznikoff CA, Brankow DW, Heidelberger C: Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 1973; 33: 3231–3238.
Rutter WJ, Pictet RL, Morris W: Towards molecular mechanisms of developmental processes. Ann Rev Biochem 1973; 42: 601–646.
Sager R, Kovac P: Pre-adipocyte determination either by insulin or by 5-azacytidine. Proc Nall Acad Sci (USA) 1982; 79: 480–484.
Santi DV, Garrett CE, Barr PJ: On the mechanisms of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 1983; 33: 9–10.
Silagi S, Graf LH: Induction of melanin and plasminogen activator by 5-azacytidine (abstract) J Cell Biol 1981; 91: 1023.
Stoner GD, Shimkin MB, Kniazeff AJ, Weisberger JH, Weisburger EK, Gori GB: Test for carcinogenicity of food additives and chemotherapeutic agents by pulmonary tumor response in Strain A mice. Cancer Res 1973; 33: 3069–3085.
Tanaka M, Hibasami H, Nagai J, Ikeda T: Effects of 5-azacytidine on DNA methylation in Ehrlichs’ ascites tumor cells. Aust J Exp Biol Med Sci 1980; 58: 391–396.
Taylor SM, Jones PA: Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979; 17: 771–779.
Taylor SM, Jones PA: Changes in phenotypic expression in embryonic and adult cells treated with 5-azacytidine. J Cell Physiol 1982a; 111: 187–194.
Taylor SM, Jones PA: Mechanisms of action of eukaryotic DNA methyltransferase: use of 5-azacytosine containing DNA. J Mol Biol 1982b; 162: 679–692.
Tennant RW, Olten JA, Myer FE, Rascati RJ: Induction of retrovirus gene expression in mouse cells by some chemical mutagens. Cancer Res 1982; 42: 3050–3055.
Tseng W-C, Medina D, Randerath K: Specific inhibition of transfer RNA methylation and modification in tissues of mice treated with 5-fluorouracil. Cancer Res 1978; 38: 1250–1257.
Venolia L, Gartler SM, Wassman ER, Yen P, Mohandas T, Shapiro LJ: Transformation with DNA from 5-azacytidine-reactivated X chromosomes. Proc Natl Acad Sci (USA) 1982; 79: 2352–2354.
Vesely J, Cihak A: High frequency induction in vivo of mouse leukemia in the AKR strain by 5-azacytidine. Experimentia 1973; 29: 1132–1133.
Vesely J, Cihak A: 5-Azacytidine: mechanism of action and biological effects in mammalian cells. Pharmac. Ther 1978; 2: 813–840.
Viegas-Pequignot E, Dutrillaux B: Segmentation of human chromosomes induced by 5-ACR (5-azacytidine). Human Genet 1975; 34: 247–254.
Viegas-Pequignot E, Dutrillaux B: Detection of G-C rich heterochromatin by 5-azacytidine in mammals. Human Genet 1981; 57: 134–137.
Weiss JW, Pitot HC: Alteration of ribosomal precursor RNA in Novikoff hepatoma cells by 5-azacytidine. Studies on methylation of 45S and 32S RNA. Arch Biochem Biophys 1974; 165: 588–596.
Weiss JW, Pitot HC: Effects of 5-azacytidine on nucleolar RNA and preribosomal particles in Novikoff hepatoma cells. Biochemistry 1975; 14: 316–326.
Wilson VL, Jones PA: DNA methylation decreases in aging but not in immortal cells. Science 1983; 220: 1055–1057.
Wilson VL, Momparler RL, Jones PA: Inhibiton of DNA methylation of L1210 leukemic cells by 5-aza-21-deoxycytidine: A possible mechanism of chemotherapeutic action. Cancer Res 1983; 43: 3493–3496.
Wolf SF, Migeon BR: Studies on X chromosome DNA methylation in normal human cells. Nature 1982; 295: 667–672.
Woodcock DM, Adam JK, Allan RG, Cooper IA: Effect of several inhibitors of enzymatic DNA methylation on the in vivo methylation of different classes of DNA sequences in a cultured human cell line. Nucl Acids Res 1983; 11: 489–499.
Worton RG, Grant SA, Duff C: Gene inactivation and reactivation at the EMT locus in Chinese hamster cells, in Sternberg NL, Pearson ML, (eds): Gene Transfer and Cancer. New York, Raven Press, (in press, 1983).
Zadrazil S, Fucik V, Bartl P, Sormova Z, Sorm F: The structure of DNA from Escherichia Coli cultured in the presence of 5-azacytidine. Biochim Biophys Acta 1965; 108: 701–703.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Jones, P.A. (1984). Gene Activation by 5-Azacytidine. In: Razin, A., Cedar, H., Riggs, A.D. (eds) DNA Methylation. Springer Series in Molecular Biology. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-8519-6_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-8519-6_9
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4613-8521-9
Online ISBN: 978-1-4613-8519-6
eBook Packages: Springer Book Archive